T1	Participants 108 140	population-based screening study
T2	Participants 202 293	prostate cancer and benign conditions of the prostate in a population-based screening study
T3	Participants 597 626	10,865 men have been screened
T4	Participants 1200 1246	1202 men studied, 361 cases of prostate cancer
T5	Participants 650 693	1202 men with PSA levels of 4 ng/mL or more
